GLI1, CTNNB1 and NOTCH1 protein expression in a thymic epithelial malignancy tissue microarray

Anticancer Research

Volumn 35, Issue 2, 2015, Pages 669-676

  Riess, Jonathan W ^a,b   West, Robert ^b   Dean, Michelle ^c   Klimowicz, Alex C ^c   Neal, Joel W ^b   Hoang, Chuong ^b   Wakelee, Heather A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TOM BAKER CANCER CENTRE   (Canada)

Author keywords

Beta catenin; Immunohistochemistry; Notch; Sonic hedgehog; Thymoma

Indexed keywords

BETA CATENIN; CTNNB1 PROTEIN, HUMAN; GLI1 PROTEIN, HUMAN; NOTCH1 PROTEIN, HUMAN; NOTCH1 RECEPTOR; TRANSCRIPTION FACTOR;

FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; MALE; METABOLISM; NEOPLASM; PATHOLOGY; THYMOMA; TISSUE MICROARRAY;

BETA CATENIN; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MALE; NEOPLASMS, GLANDULAR AND EPITHELIAL; RECEPTOR, NOTCH1; THYMUS NEOPLASMS; TISSUE ARRAY ANALYSIS; TRANSCRIPTION FACTORS;

EID: 84923690642     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Temes R, Chavez T, Mapel D, Ketai L, Crowell R, Key C, Follis F, Pett S, Wernly J, Temes R, Chavez T, Mapel D, Ketai L, Crowell R, Key C, Follis F, Pett S and Wernly J: Primary mediastinal malignancies: findings in 219 patients. Western Journal of Medicine 170(3): 161-6, 1999.
2. Tomaszek S, Wigle DA, Keshavjee S, Fischer S, Tomaszek S, Wigle DA, Keshavjee S and Fischer S: Thymomas: review of current clinical practice. Ann Thorac Surg 87(6): 1973-80, 2009.
3. Girard N: Thymic tumors: relevant molecular data in the clinic. J Thorac Oncol 5(10 Suppl 4): S291-5, 2010.
4. Gilbert SF. Developmental biology. 9th ed. Sunderland, Mass.: Sinauer Associates; 2010.
5. D'Angelo RC and Wicha MS: Stem cells in normal development and cancer. Prog Mol Biol Transl Sci 95: 113-58, 2010.
6. Ingham PW: Hedgehog signaling: a tale of two lipids. Science 294(5548): 1879-81, 2001.
7. Outram SV, Varas A, Pepicelli CV and Crompton T: Hedgehog signaling regulates differentiation from double-negative to double-positive thymocyte. Immunity 13(2): 187-97, 2000.
8. Uhmann A, Dittmann K, Nitzki F, Dressel R, Koleva M, Frommhold A, Zibat A, Binder C, Adham I, Nitsche M, Heller T, Armstrong V, Schulz-Schaeffer W, Wienands J and Hahn H: The Hedgehog receptor Patched controls lymphoid lineage commitment. Blood 110(6): 1814-23, 2007.
9. Uhmann A, van den Brandt J, Dittmann K, Hess I, Dressel R, Binder C, Luhder F, Christiansen H, Fassnacht M, Bhandoola A, Wienands J, Reichardt HM and Hahn H: T cell development critically depends on prethymic stromal patched expression. J Immunol 186(6): 3383-91, 2011.
10. Tasaki A, Akiyoshi T, Koga K, Nakashima H, Yamanaka N, Kubo M, Matsumoto K, Kojima M, Tanaka M, Nakamura M and Katano M: Immunohistochemical staining of hedgehog pathway-related proteins in human thymomas. Anticancer Res 25(6A): 3697-701, 2005.
11. Artavanis-Tsakonas S, Rand MD and Lake RJ: Notch signaling: cell fate control and signal integration in development. Science 284(5415): 770-6, 1999.
12. Ranganathan P, Weaver KL and Capobianco AJ: Notch signal- ling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer 11(5): 338-51, 2011.
13. Laky K and Fowlkes BJ: Notch signaling in CD4 and CD8 T cell development. Curr Opin Immunol 20(2): 197-202, 2008.
14. Masuda K, Germeraad WT, Satoh R, Itoi M, Ikawa T, Minato N, Katsura Y, van Ewijk W and Kawamoto H: Notch activation in thymic epithelial cells induces development of thymic micro-environments. Mol Immunol 46(8-9): 1756-67, 2009.
15. Grigoryan T, Wend P, Klaus A and Birchmeier W: Deciphering the function of canonical Wnt signals in develop ment and disease: conditional loss- and gain-of-function mutations of betacatenin in mice. Genes Dev 22(17): 2308-41, 2008.
16. Takebe N, Harris PJ, Warren RQ and Ivy SP: Targeting cancer stem cells by inhibiting Wnt, Notch and Hedgehog pathways. Nat Rev Clin Oncol 8(2): 97-106, 2011.
17. Reya T and Clevers H: Wnt signalling in stem cells and cancer. Nature 434( 7035): 843-50, 2005.
18. Zuklys S, Gill J, Keller MP, Hauri-Hohl M, Zhanybekova S, Balciunaite G, Na KJ, Jeker LT, Hafen K, Tsukamoto N, Amagai T, Taketo MM, Krenger W and Hollander GA: Stabilized betacatenin in thymic epithelial cells blocks thymus development and function. J Immunol 182(5): 2997-3007, 2009.
19. Pongracz J, Hare K, Harman B anderson G and Jenkinson EJ: Thymic epithelial cells provide WNT signals to developing thymocytes. Eur J Immunol 33(7): 1949-56, 2003.
20. Yoshino I, Kase S, Yano T, Sugio K and Sugimachi K: Expression status of E-cadherin and alpha-, beta- and gammacatenins in thymoma. Ann Thorac Surg 73(3): 933-7, 2002.
21. Pan CC, Ho DM, Chen WY, Chiang H, Fahn HJ and Wang LS: Expression of E-cadherin and alpha- and beta-catenins in thymoma. J Pathol 184(2): 207-11, 1998.
22. Von Hoff DD, LoRusso PM, Rudin CM, Reddy JC, Yauch RL, Tibes R, Weiss GJ, Borad MJ, Hann CL, Brahmer JR, Mackey HM, Lum BL, Darbonne WC, Marsters JC, Jr., de Sauvage FJ and Low JA: Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 361(12): 1164-72, 2009.
23. Peters JU, Galley G, Jacobsen H, Czech C, David-Pierson P, Kitas EA and Ozmen L: Novel orally active, dibenzazepinonebased gamma-secretase inhibitors. Bioorg Med Chem Lett 17(21): 5918-23, 2007.
24. Camp RL, Chung GG and Rimm DL: Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med 8( 11): 1323-7, 2002.
25. Brockton NT, Klimowicz AC, Bose P, Petrillo SK, Konno M, Rudmik L, Dean M, Nakoneshny SC, Matthews TW, Chandarana S, Lau HY, Magliocco AM and Dort JC: High stromal carbonic anhydrase IX expression is associated with nodal metastasis and decreased survival in patients with surgically-treated oral cavity squamous cell carcinoma. Oral Oncol 48( 7): 615-22, 2012.
26. Escobar J, Klimowicz AC, Dean M, Chu P, Nation JG, Nelson GS, Ghatage P, Kalloger SE and Kobel M: Quantification of ER/PR expression in ovarian low-grade serous carcinoma. Gynecol Oncol 128(2): 371-6, 2013.
27. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C, McKenna A, Shefler E, Ramos AH, Stojanov P, Carter SL, Voet D, Cortes ML, Auclair D, Berger MF, Saksena G, Guiducci C, Onofrio RC, Parkin M, Romkes M, Weissfeld JL, Seethala RR, Wang L, Rangel-Escareno C, Fernandez-Lopez JC, Hidalgo-Miranda A, Melendez-Zajgla J, Winckler W, Ardlie K, Gabriel SB, Meyerson M, Lander ES, Getz G, Golub TR, Garraway LA and Grandis JR: The mutational landscape of head and neck squamous cell carcinoma. Science 333(6046): 1157-60, 2011.
28. Comprehensive genomic characterization of squamous cell lung cancers. Nature 489(7417): 519-25, 2012.
29. Badve S, Goswami C, Gokmen-Polar Y, Nelson RP, Jr., Henley J, Miller N, Zaheer NA, Sledge GW, Jr., Li L, Kesler KA and Loehrer PJ, Sr.: Molecular analysis of thymoma. PLoS One 7(8): e42669, 2012.